Who is sponsoring NCT00792168?

NCT00792168 is sponsored by University of California, Los Angeles.

What condition does NCT00792168 study?

NCT00792168 studies Major Depression.

What drugs are being tested in NCT00792168?

Interventions: venlafaxine (Effexor), placebo.

What is the status of NCT00792168?

NCT00792168 is currently COMPLETED.

Last reviewed 2025-12-16 · How we verify

Physiologic Monitoring of Antidepressant Treatment Response

NCT00792168 Phase 4 COMPLETED

Primary: to identify physiologic indicators of venlafaxine treatment response using quantitative EEG (QEEG) cordance, and to determine if cordance changes are specifically associated with response to venlafaxine; Secondary: to determine if cordance changes early in the course (i.e., prior to improvement in clinical symptoms) of venlafaxine (or another antidepressant if venlafaxine is not clinically indicated for a particular patient) are predictive of later clinical response.

Details

Lead sponsor	University of California, Los Angeles
Phase	Phase 4
Status	COMPLETED
Enrolment	38
Start date	1996-11
Completion	1998-12

Conditions

Major Depression

Interventions

venlafaxine (Effexor)
placebo

Primary outcomes

quantitative electroencephalography (QEEG) — 6 QEEG measurements (end of wash-in, and 48 hours, 1 week, 2 weeks, 4 weeks, and 8 weeks after randomized treatment)

Countries

United States